Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 - The Lancet Rheumatology
Osteoarthritis - The Lancet
One billion people globally to have osteoarthritis by 2050: Lancet Study - The Economic Times
Erosive hand osteoarthritis: latest findings and outlook | Nature Reviews Rheumatology
Osteoarthritis in 2020 and beyond: a Lancet Commission - The Lancet
Mechanisms of osteoarthritis in the knee: MR imaging appearance - Shapiro - 2014 - Journal of Magnetic Resonance Imaging - Wiley Online Library
Osteoarthritis - The Lancet
Pathogenesis and management of pain in osteoarthritis - The Lancet
Osteoarthritis - The Lancet
Around 1 bn people globally will live with osteoarthritis by 2050, says Lancet study - The Economic Times
One billion people globally to have osteoarthritis by 2050: Lancet study | Health - Hindustan Times
Osteoarthritis Analysed In Lancet Study | Latest Update | Drishti IAS English - YouTube
Osteoarthritis: an update with relevance for clinical practice - The Lancet
/newsdrum-in/media/media_files/luX6kWxEbcQyVap3Bg3L.jpeg "Nearly one billion people globally will have osteoarthritis by 2050: Lancet study")
Nearly one billion people globally will have osteoarthritis by 2050: Lancet study
Osteoarthritis - The Lancet
One billion people globally to have osteoarthritis by 2050: Lancet Study, ET HealthWorld
Frontiers | Non-viral Gene Therapy for Osteoarthritis
IJMS | Free Full-Text | Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis
Osteoarthritis - The Lancet
Frontiers | G Protein-Coupled Receptors in Osteoarthritis: A Novel Perspective on Pathogenesis and Treatment
What Is Osteoarthritis? | Arthritis-health
Biology | Free Full-Text | Pathogenesis of Osteoarthritis: Risk Factors, Regulatory Pathways in Chondrocytes, and Experimental Models
What Is Osteoarthritis? | Arthritis-health
Osteoarthritis - The Lancet
One billion people globally to have osteoarthritis by 2050: Lancet Study | The Financial Express
